The BREATHE (Boosting REsources And caregiver empowerment for Tracheostomy care at HomE) study is a five-year, six-hospital trial that will advance understanding of how hospitals can better support caregivers of children with tracheostomies as they resume life, work, and family activities after discharge.
This is a case report of an upper parapharyngeal abscess arising from the progression of a central skull base osteomyelitis in a patient with poorly controlled diabetes mellitus. It’s unusual for its presentation in an upper parapharyngeal location, involvement of the skull base, and poor response to medical treatment, hence requiring transnasal endoscopic surgical drainage to achieve definitive treatment.
This is a case of an 85-year-old patient with a cT2N0 laryngeal squamous cell carcinoma treated using CO2 transoral laser exoscopic surgery (TOLES).
Opioid prescription patterns among sleep surgeons in the U.S. remained stable from 2013 to 2021; surgeons with longer tenures exhibited higher rates of opioid prescribing during this time.
The topical beta-blocker timolol can be an effective first-line treatment for controlling symptoms of ulcerated IHs; however, its use should be carefully monitored.
Leukotriene Modulator a Safe Pharmacological Option for Children with Adenoid Hypertrophy
PRP injections resulted in improved patient-reported outcome measures and auditory–perceptual measures of voice and are a promising treatment option for vocal fold scar and sulci.
Biochemical Composition of the Dorsal Septal Cartilage May Contribute to Weakening and Ultimate Nasal Valve Compromise
Over the past few decades, a transition toward culture-directed antibiotics has shifted the treatment paradigm of SBO toward primary medical management, with mortality rates now decreasing to 10-20% compared to 50% initially.
HNS was approved by the U.S. Food and Drug Administration in 2014 as a treatment option for patients with moderate to severe OSA who cannot tolerate CPAP.